Literature DB >> 23433961

The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases.

Eveline Boudin1, Igor Fijalkowski, Elke Piters, Wim Van Hul.   

Abstract

OBJECTIVES: The Wnt signaling pathway is a key pathway in various processes, including bone metabolism. In this review, current knowledge of all extracellular modulators of the canonical Wnt signaling in bone metabolism is summarized and discussed.
METHODS: The PubMed database was searched using the following keywords: canonical Wnt signaling, β-catenin bone metabolism, BMD, osteoblast, osteoporosis, Wnt, LRPs, Frizzleds, sFRPs, sclerostin or SOST, dickkopfs, Wif1, R-spondins, glypicans, SOST-dc1 and kremen, all separately as well as in different combinations.
RESULTS: Canonical Wnt signaling is considered to be one of the major pathways regulating bone formation. Consequently, a large number of studies were performed to elucidate the role of numerous proteins in canonical Wnt signaling and bone metabolism. These studies led to the identification of novel modulators of the pathway like the R-spondin and glypican protein families. Furthermore novel insights are gained in the regulatory role of the different Wnt proteins. Finally, due to its function in bone formation, the pathway is an interesting target for the development of therapeutics for osteoporosis and other bone diseases. In this review, we discuss the promising results of the Wnt modulators sclerostin, Dkk1 and sFRP1 as targets for osteoporosis treatment.
CONCLUSION: The increasing number of studies into the exact function of all proteins in the canonical Wnt pathway in general and in bone metabolism already led to novel insights in the regulation of the canonical Wnt pathway. In this review we covered the current knowledge of all extracellular modulators of canonical Wnt signaling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone metabolism; Osteoporosis; Wnt signaling; β-catenin

Mesh:

Substances:

Year:  2013        PMID: 23433961     DOI: 10.1016/j.semarthrit.2013.01.004

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  25 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

2.  Role of Sost in Wnt signal pathway in osteoporosis rats and regulating effect of soybean isoflavones on Wnt signal pathway.

Authors:  Hai Dong Liang; Fang Yu; Ping Lv; Zheng Nan Zhao; Zhi Hong Tong
Journal:  Mol Biol Rep       Date:  2014-04-24       Impact factor: 2.316

Review 3.  Role of syndecan-2 in osteoblast biology and pathology.

Authors:  Rafik Mansouri; Eric Haÿ; Pierre J Marie; Dominique Modrowski
Journal:  Bonekey Rep       Date:  2015-04-01

Review 4.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 5.  Human Genetics of Sclerosing Bone Disorders.

Authors:  Raphaël De Ridder; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

6.  Shikonin promotes osteogenesis and suppresses osteoclastogenesis in vitro.

Authors:  Liang Zhou; Jiaqian Wang; Jiali Zhao; Feng Kuai; Huilin Yang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

7.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

Review 8.  The osteocyte as a therapeutic target in the treatment of osteoporosis.

Authors:  Gaël Y Rochefort
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

9.  Joint dysfunction and functional decline in middle age myostatin null mice.

Authors:  Wen Guo; Andrew D Miller; Karol Pencina; Siu Wong; Amanda Lee; Michael Yee; Gianluca Toraldo; Ravi Jasuja; Shalender Bhasin
Journal:  Bone       Date:  2015-11-05       Impact factor: 4.398

10.  Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Authors:  Matthew M Roforth; Koji Fujita; Ulrike I McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.